Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 268 entries
Sorted by: Best Match Show Resources per page
SU-E-T-562: Reducing the Arc Span for CSA VMAT Delivery.

Medical physics

Myers P, Stathakis S, Gutierrez A, Esquivel C, Mavroidis P, Papanikolaou N.
PMID: 28517078
Med Phys. 2012 Jun;39(6):3835. doi: 10.1118/1.4735651.

PURPOSE: To dosimetrically evaluate advantages and disadvantages of using multiple, shorter, sub-arcs versus full arc deliveries for treatment of cranio-spinal axis (CSA) irradiation.METHODS: Five (n=5) cranio-spinal axis irradiation patients were planned using 2 complete arcs, one superior and one...

Cite
Myers P, Stathakis S, Gutierrez A, et al. SU-E-T-562: Reducing the Arc Span for CSA VMAT Delivery. Med Phys. 2012;39(6):3835doi: 10.1118/1.4735651.
Myers, P., Stathakis, S., Gutierrez, A., Esquivel, C., Mavroidis, P., & Papanikolaou, N. (2012). SU-E-T-562: Reducing the Arc Span for CSA VMAT Delivery. Medical physics, 39(6), 3835. https://doi.org/10.1118/1.4735651
Myers, P, et al. "SU-E-T-562: Reducing the Arc Span for CSA VMAT Delivery." Medical physics vol. 39,6 (2012): 3835. doi: https://doi.org/10.1118/1.4735651
Myers P, Stathakis S, Gutierrez A, Esquivel C, Mavroidis P, Papanikolaou N. SU-E-T-562: Reducing the Arc Span for CSA VMAT Delivery. Med Phys. 2012 Jun;39(6):3835. doi: 10.1118/1.4735651. PMID: 28517078.
Copy Download .nbib Format: NLM
Robert L. Replogle (1931-2016).

World journal for pediatric & congenital heart surgery

Mavroudis C.
PMID: 27358295
World J Pediatr Congenit Heart Surg. 2016 Jul;7(4):423-4. doi: 10.1177/2150135116656170.

No abstract available.

Cite
Mavroudis C. Robert L. Replogle (1931-2016). World J Pediatr Congenit Heart Surg. 2016;7(4):423-4doi: 10.1177/2150135116656170.
Mavroudis, C. (2016). Robert L. Replogle (1931-2016). World journal for pediatric & congenital heart surgery, 7(4), 423-4. https://doi.org/10.1177/2150135116656170
Mavroudis, Constantine. "Robert L. Replogle (1931-2016)." World journal for pediatric & congenital heart surgery vol. 7,4 (2016): 423-4. doi: https://doi.org/10.1177/2150135116656170
Mavroudis C. Robert L. Replogle (1931-2016). World J Pediatr Congenit Heart Surg. 2016 Jul;7(4):423-4. doi: 10.1177/2150135116656170. PMID: 27358295.
Copy Download .nbib Format: NLM
Uncontrolled diabetes resulting in diabetic cardiomyopathy in a young male patient and eventually presenting with a stroke.

Journal of family medicine and primary care

Kritikos K, Soitou K, Kapranou R, Mavroidis N.
PMID: 25657971
J Family Med Prim Care. 2014 Oct-Dec;3(4):470-2. doi: 10.4103/2249-4863.148155.

Diabetic cardiomyopathy (DCP) is defined as the cardiovascular damage present in diabetes patients, which is characterized by myocardial dilatation and hypertrophy, as well as a decrease in the systolic and diastolic function of the left ventricle, and its presence...

Cite
Kritikos K, Soitou K, Kapranou R, et al. Uncontrolled diabetes resulting in diabetic cardiomyopathy in a young male patient and eventually presenting with a stroke. J Family Med Prim Care. 2014;3(4):470-2doi: 10.4103/2249-4863.148155.
Kritikos, K., Soitou, K., Kapranou, R., & Mavroidis, N. (2014). Uncontrolled diabetes resulting in diabetic cardiomyopathy in a young male patient and eventually presenting with a stroke. Journal of family medicine and primary care, 3(4), 470-2. https://doi.org/10.4103/2249-4863.148155
Kritikos, Konstantinos, et al. "Uncontrolled diabetes resulting in diabetic cardiomyopathy in a young male patient and eventually presenting with a stroke." Journal of family medicine and primary care vol. 3,4 (2014): 470-2. doi: https://doi.org/10.4103/2249-4863.148155
Kritikos K, Soitou K, Kapranou R, Mavroidis N. Uncontrolled diabetes resulting in diabetic cardiomyopathy in a young male patient and eventually presenting with a stroke. J Family Med Prim Care. 2014 Oct-Dec;3(4):470-2. doi: 10.4103/2249-4863.148155. PMID: 25657971; PMCID: PMC4311370.
Copy Download .nbib Format: NLM
Prophylactic arrhythmia surgery in association with congenital heart disease.

Translational pediatrics

Mavroudis C, Deal BJ.
PMID: 27709096
Transl Pediatr. 2016 Jul;5(3):148-159. doi: 10.21037/tp.2016.06.04.

Certain congenital heart anomalies make patients more susceptible to arrhythmia development throughout their lives. This poses the question whether prophylactic arrhythmia surgery should be incorporated into reparative open heart procedures for congenital heart disease. There is currently no consensus...

Cite
Mavroudis C, Deal BJ. Prophylactic arrhythmia surgery in association with congenital heart disease. Transl Pediatr. 2016;5(3):148-159doi: 10.21037/tp.2016.06.04.
Mavroudis, C., & Deal, B. J. (2016). Prophylactic arrhythmia surgery in association with congenital heart disease. Translational pediatrics, 5(3), 148-159. https://doi.org/10.21037/tp.2016.06.04
Mavroudis, Constantine, and Deal, Barbara J. "Prophylactic arrhythmia surgery in association with congenital heart disease." Translational pediatrics vol. 5,3 (2016): 148-159. doi: https://doi.org/10.21037/tp.2016.06.04
Mavroudis C, Deal BJ. Prophylactic arrhythmia surgery in association with congenital heart disease. Transl Pediatr. 2016 Jul;5(3):148-159. doi: 10.21037/tp.2016.06.04. PMID: 27709096; PMCID: PMC5035756.
Copy Download .nbib Format: NLM
A Comparison of the Elastic Properties of Graphene- and Fullerene-Reinforced Polymer Composites: The Role of Filler Morphology and Size.

Scientific reports

Lu CT, Weerasinghe A, Maroudas D, Ramasubramaniam A.
PMID: 27546738
Sci Rep. 2016 Aug 22;6:31735. doi: 10.1038/srep31735.

Nanoscale carbon-based fillers are known to significantly alter the mechanical and electrical properties of polymers even at relatively low loadings. We report results from extensive molecular-dynamics simulations of mechanical testing of model polymer (high-density polyethylene) nanocomposites reinforced by nanocarbon...

Cite
Lu CT, Weerasinghe A, Maroudas D, et al. A Comparison of the Elastic Properties of Graphene- and Fullerene-Reinforced Polymer Composites: The Role of Filler Morphology and Size. Sci Rep. 2016;6:31735doi: 10.1038/srep31735.
Lu, C. T., Weerasinghe, A., Maroudas, D., & Ramasubramaniam, A. (2016). A Comparison of the Elastic Properties of Graphene- and Fullerene-Reinforced Polymer Composites: The Role of Filler Morphology and Size. Scientific reports, 631735. https://doi.org/10.1038/srep31735
Lu, Chang-Tsan, et al. "A Comparison of the Elastic Properties of Graphene- and Fullerene-Reinforced Polymer Composites: The Role of Filler Morphology and Size." Scientific reports vol. 6 (2016): 31735. doi: https://doi.org/10.1038/srep31735
Lu CT, Weerasinghe A, Maroudas D, Ramasubramaniam A. A Comparison of the Elastic Properties of Graphene- and Fullerene-Reinforced Polymer Composites: The Role of Filler Morphology and Size. Sci Rep. 2016 Aug 22;6:31735. doi: 10.1038/srep31735. PMID: 27546738; PMCID: PMC4992834.
Copy Download .nbib Format: NLM
Quo vadis computational analysis of PPI data or why the future isn't here yet.

Frontiers in genetics

Theofilatos KA, Likothanassis S, Mavroudi S.
PMID: 26442107
Front Genet. 2015 Sep 15;6:289. doi: 10.3389/fgene.2015.00289. eCollection 2015.

No abstract available.

Cite
Theofilatos KA, Likothanassis S, Mavroudi S. Quo vadis computational analysis of PPI data or why the future isn't here yet. Front Genet. 2015;6:289doi: 10.3389/fgene.2015.00289.
Theofilatos, K. A., Likothanassis, S., & Mavroudi, S. (2015). Quo vadis computational analysis of PPI data or why the future isn't here yet. Frontiers in genetics, 6289. https://doi.org/10.3389/fgene.2015.00289
Theofilatos, Konstantinos A, et al. "Quo vadis computational analysis of PPI data or why the future isn't here yet." Frontiers in genetics vol. 6 (2015): 289. doi: https://doi.org/10.3389/fgene.2015.00289
Theofilatos KA, Likothanassis S, Mavroudi S. Quo vadis computational analysis of PPI data or why the future isn't here yet. Front Genet. 2015 Sep 15;6:289. doi: 10.3389/fgene.2015.00289. eCollection 2015. PMID: 26442107; PMCID: PMC4584938.
Copy Download .nbib Format: NLM
Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study.

Journal of medical physics

Narayanasamy G, Pyakuryal AP, Pandit S, Vincent J, Lee C, Mavroidis P, Papanikolaou N, Kudrimoti M, Sio TT.
PMID: 26500403
J Med Phys. 2015 Jul-Sep;40(3):165-9. doi: 10.4103/0971-6203.165075.

In clinical practice, evaluation of clinical efficacy of treatment planning stems from the radiation oncologist's experience in accurately targeting tumors, while keeping minimal toxicity to various organs at risk (OAR) involved. A more objective, quantitative method may be raised...

Cite
Narayanasamy G, Pyakuryal AP, Pandit S, et al. Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study. J Med Phys. 2015;40(3):165-9doi: 10.4103/0971-6203.165075.
Narayanasamy, G., Pyakuryal, A. P., Pandit, S., Vincent, J., Lee, C., Mavroidis, P., Papanikolaou, N., Kudrimoti, M., & Sio, T. T. (2015). Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study. Journal of medical physics, 40(3), 165-9. https://doi.org/10.4103/0971-6203.165075
Narayanasamy, G, et al. "Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study." Journal of medical physics vol. 40,3 (2015): 165-9. doi: https://doi.org/10.4103/0971-6203.165075
Narayanasamy G, Pyakuryal AP, Pandit S, Vincent J, Lee C, Mavroidis P, Papanikolaou N, Kudrimoti M, Sio TT. Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study. J Med Phys. 2015 Jul-Sep;40(3):165-9. doi: 10.4103/0971-6203.165075. PMID: 26500403; PMCID: PMC4594386.
Copy Download .nbib Format: NLM
Mechanisms and energetics of hydride dissociation reactions on surfaces of plasma-deposited silicon thin films.

The Journal of chemical physics

Singh T, Valipa MS, Mountziaris TJ, Maroudas D.
PMID: 18035894
J Chem Phys. 2007 Nov 21;127(19):194703. doi: 10.1063/1.2781393.

We report results from a detailed analysis of the fundamental silicon hydride dissociation processes on silicon surfaces and discuss their implications for the surface chemical composition of plasma-deposited hydrogenated amorphous silicon (a-Si:H) thin films. The analysis is based on...

Cite
Singh T, Valipa MS, Mountziaris TJ, et al. Mechanisms and energetics of hydride dissociation reactions on surfaces of plasma-deposited silicon thin films. J Chem Phys. 2007;127(19):194703doi: 10.1063/1.2781393.
Singh, T., Valipa, M. S., Mountziaris, T. J., & Maroudas, D. (2007). Mechanisms and energetics of hydride dissociation reactions on surfaces of plasma-deposited silicon thin films. The Journal of chemical physics, 127(19), 194703. https://doi.org/10.1063/1.2781393
Singh, Tejinder, et al. "Mechanisms and energetics of hydride dissociation reactions on surfaces of plasma-deposited silicon thin films." The Journal of chemical physics vol. 127,19 (2007): 194703. doi: https://doi.org/10.1063/1.2781393
Singh T, Valipa MS, Mountziaris TJ, Maroudas D. Mechanisms and energetics of hydride dissociation reactions on surfaces of plasma-deposited silicon thin films. J Chem Phys. 2007 Nov 21;127(19):194703. doi: 10.1063/1.2781393. PMID: 18035894.
Copy Download .nbib Format: NLM
Som-based class discovery exploring the ICA-reduced features of microarray expression profiles.

Comparative and functional genomics

Dragomir A, Mavroudi S, Bezerianos A.
PMID: 18629176
Comp Funct Genomics. 2004;5(8):596-616. doi: 10.1002/cfg.444.

Gene expression datasets are large and complex, having many variables and unknown internal structure. We apply independent component analysis (ICA) to derive a less redundant representation of the expression data. The decomposition produces components with minimal statistical dependence and...

Cite
Dragomir A, Mavroudi S, Bezerianos A. Som-based class discovery exploring the ICA-reduced features of microarray expression profiles. Comp Funct Genomics. 2004;5(8):596-616doi: 10.1002/cfg.444.
Dragomir, A., Mavroudi, S., & Bezerianos, A. (2004). Som-based class discovery exploring the ICA-reduced features of microarray expression profiles. Comparative and functional genomics, 5(8), 596-616. https://doi.org/10.1002/cfg.444
Dragomir, Andrei, et al. "Som-based class discovery exploring the ICA-reduced features of microarray expression profiles." Comparative and functional genomics vol. 5,8 (2004): 596-616. doi: https://doi.org/10.1002/cfg.444
Dragomir A, Mavroudi S, Bezerianos A. Som-based class discovery exploring the ICA-reduced features of microarray expression profiles. Comp Funct Genomics. 2004;5(8):596-616. doi: 10.1002/cfg.444. PMID: 18629176; PMCID: PMC2447468.
Copy Download .nbib Format: NLM
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Souglakos J, Vardakis N, Androulakis N, Kakolyris S, Kouroussis Ch, Mavroudis D, Pallis A, Agelaki S, Kalbakis K, Georgoulias V.
PMID: 17335131
J BUON. 2005 Jan-Mar;10(1):47-52.

PURPOSE: A phase II study was conducted to evaluate the toxicity and efficacy of irinotecan (CPT-11), 5-fluorouracil/leucovorin (5-FU/LV) (AIO regimen) as salvage treatment in patients with metastatic colorectal cancer (MCC).PATIENTS AND METHODS: Thirty-three patients relapsing after oxaliplatin-based first line...

Cite
Souglakos J, Vardakis N, Androulakis N, et al. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial. J BUON. 2005;10(1):47-52
Souglakos, J., Vardakis, N., Androulakis, N., Kakolyris, S., Kouroussis, C. h., Mavroudis, D., Pallis, A., Agelaki, S., Kalbakis, K., & Georgoulias, V. (2005). Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 10(1), 47-52.
Souglakos, J, et al. "Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial." Journal of B.U.ON. : official journal of the Balkan Union of Oncology vol. 10,1 (2005): 47-52.
Souglakos J, Vardakis N, Androulakis N, Kakolyris S, Kouroussis Ch, Mavroudis D, Pallis A, Agelaki S, Kalbakis K, Georgoulias V. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial. J BUON. 2005 Jan-Mar;10(1):47-52. PMID: 17335131.
Copy Download .nbib Format: NLM
Imaging after double passage through a random screen.

Optics letters

Mavroidis T, Dainty JC.
PMID: 19768101
Opt Lett. 1990 Aug 01;15(15):857-9. doi: 10.1364/ol.15.000857.

The average intensity spectrum is derived for an object illuminated and viewed through the same random screen. This double passage is shown to give an average image that contains diffraction-limited information about the Fourier modulus of the object amplitude.

Cite
Mavroidis T, Dainty JC. Imaging after double passage through a random screen. Opt Lett. 1990;15(15):857-9doi: 10.1364/ol.15.000857.
Mavroidis, T., & Dainty, J. C. (1990). Imaging after double passage through a random screen. Optics letters, 15(15), 857-9. https://doi.org/10.1364/ol.15.000857
Mavroidis, T, and Dainty, J C. "Imaging after double passage through a random screen." Optics letters vol. 15,15 (1990): 857-9. doi: https://doi.org/10.1364/ol.15.000857
Mavroidis T, Dainty JC. Imaging after double passage through a random screen. Opt Lett. 1990 Aug 01;15(15):857-9. doi: 10.1364/ol.15.000857. PMID: 19768101.
Copy Download .nbib Format: NLM
Organotin Compound Derived from 3-Hydroxy-2-formylpyridine Semicarbazone: Synthesis, Crystal Structure, and Antiproliferative Activity.

Bioinorganic chemistry and applications

Wiecek J, Kovala-Demertzi D, Ciunik Z, Wietrzyk J, Zervou M, Demertzis MA.
PMID: 20490260
Bioinorg Chem Appl. 2010;718606. doi: 10.1155/2010/718606. Epub 2010 May 12.

The novel diphenyltin(IV) compound [Ph(2)(HyFoSc)Sn] (2), where H(2)HyFoSc (1) is 3-hydroxy-2-formylpyridine semicarbazone, was prepared and characterized by vibrational and NMR ((1)H, (13)C) spectroscopy. The structure of [Ph(2)(HyFoSc)Sn] was confirmed by single-crystal X-ray crystallography. The doubly deprotonated ligand is coordinated...

Cite
Wiecek J, Kovala-Demertzi D, Ciunik Z, et al. Organotin Compound Derived from 3-Hydroxy-2-formylpyridine Semicarbazone: Synthesis, Crystal Structure, and Antiproliferative Activity. Bioinorg Chem Appl. 2010;718606doi: 10.1155/2010/718606.
Wiecek, J., Kovala-Demertzi, D., Ciunik, Z., Wietrzyk, J., Zervou, M., & Demertzis, M. A. (2010). Organotin Compound Derived from 3-Hydroxy-2-formylpyridine Semicarbazone: Synthesis, Crystal Structure, and Antiproliferative Activity. Bioinorganic chemistry and applications, 718606. https://doi.org/10.1155/2010/718606
Wiecek, Joanna, et al. "Organotin Compound Derived from 3-Hydroxy-2-formylpyridine Semicarbazone: Synthesis, Crystal Structure, and Antiproliferative Activity." Bioinorganic chemistry and applications vol. (2010): 718606. doi: https://doi.org/10.1155/2010/718606
Wiecek J, Kovala-Demertzi D, Ciunik Z, Wietrzyk J, Zervou M, Demertzis MA. Organotin Compound Derived from 3-Hydroxy-2-formylpyridine Semicarbazone: Synthesis, Crystal Structure, and Antiproliferative Activity. Bioinorg Chem Appl. 2010;718606. doi: 10.1155/2010/718606. Epub 2010 May 12. PMID: 20490260; PMCID: PMC2869176.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 268 entries